Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The incidence of thrombocytopenia in ICU patients with severe illness ranged from 8.3% to
67.6%, and ranged from 14% to 44% during ICU treatment.Severe patients with thrombocytopenia
also have significantly increased bleeding events and blood transfusions, and even a
significantly increased risk of death.This study examines whether elevated platelets benefit
patients with pneumonia
Phase:
Phase 4
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborators:
Shenzhen Hospital of Southern Medical University The Second People's Hospital of GuangDong Province The Third Affiliated Hospital of Southern Medical University